Association of Major Adverse Cardiac Events and Beta-Blockers in Patients with and without Atherosclerotic Cardiovascular Disease: Long-Term Follow-Up Results of the T-SPARCLE and T-PPARCLE Registry in Taiwan

Beta-blockers are widely used, but the benefit is now challenged in patients at risk of atherosclerotic cardiovascular disease (ASCVD) in the present coronary reperfusion era. We aimed to identify the risk factors of a major adverse cardiac event (MACE) and the long-term effect of beta-blockers in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Patrick Yan-Tyng, Lin, Fang-Ju, Yeh, Chih-Fan, Hsiao, Yu-Chung, Hsuan, Chin-Feng, Chang, Wei-Tien, Kao, Hsien-Li, Jeng, Jiann-Shing, Wu, Yen-Wen, Hsieh, I-Chang, Fang, Ching-Chang, Wang, Kuo-Yang, Chang, Kuan-Cheng, Lin, Tsung-Hsien, Sheu, Wayne Huey-Herng, Li, Yi-Heng, Yin, Wei-Hsian, Yeh, Hung-I, Chen, Jaw-Wen, Wu, Chau-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057487/
https://www.ncbi.nlm.nih.gov/pubmed/36983164
http://dx.doi.org/10.3390/jcm12062162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057487/
https://www.ncbi.nlm.nih.gov/pubmed/36983164
http://dx.doi.org/10.3390/jcm12062162

Ejemplares similares